{"title":"沃替西汀引起的皮肤副作用病例系列","authors":"M. Guneş, Ezginur İnan","doi":"10.5455/pbs.20210406034449","DOIUrl":null,"url":null,"abstract":"Vortioxetine is a new generation antidepressant approved for the treatment of Major Depressive Disorder (MDD). We would like to report three different cases in which dermatological side effects developed after treatment with vortioxetine. Our first case is about ichthyosis after vortioxetine intake, our second case is about acneiform rash due to vortioxetine intake, and our last case is about urticaria after vortioxetine intake. With this study, we aim to draw attention to such adverse effects of vortioxetine treatment.","PeriodicalId":74168,"journal":{"name":"MedPress psychiatry and behavioral sciences","volume":"29 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Skin Side Effects Due To Vortioxetine Case Series\",\"authors\":\"M. Guneş, Ezginur İnan\",\"doi\":\"10.5455/pbs.20210406034449\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Vortioxetine is a new generation antidepressant approved for the treatment of Major Depressive Disorder (MDD). We would like to report three different cases in which dermatological side effects developed after treatment with vortioxetine. Our first case is about ichthyosis after vortioxetine intake, our second case is about acneiform rash due to vortioxetine intake, and our last case is about urticaria after vortioxetine intake. With this study, we aim to draw attention to such adverse effects of vortioxetine treatment.\",\"PeriodicalId\":74168,\"journal\":{\"name\":\"MedPress psychiatry and behavioral sciences\",\"volume\":\"29 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"MedPress psychiatry and behavioral sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5455/pbs.20210406034449\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"MedPress psychiatry and behavioral sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5455/pbs.20210406034449","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Vortioxetine is a new generation antidepressant approved for the treatment of Major Depressive Disorder (MDD). We would like to report three different cases in which dermatological side effects developed after treatment with vortioxetine. Our first case is about ichthyosis after vortioxetine intake, our second case is about acneiform rash due to vortioxetine intake, and our last case is about urticaria after vortioxetine intake. With this study, we aim to draw attention to such adverse effects of vortioxetine treatment.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
